Use of bisphosphonates in cancer patients

Cancer Treat Rev. 1996 Jul;22(4):265-87. doi: 10.1016/s0305-7372(96)90020-1.
No abstract available

Publication types

  • Review

MeSH terms

  • Alendronate / therapeutic use
  • Bone Neoplasms / complications*
  • Bone Neoplasms / prevention & control
  • Bone Neoplasms / secondary*
  • Bone Resorption / prevention & control
  • Breast Neoplasms / complications*
  • Clodronic Acid / therapeutic use
  • Diphosphonates / chemistry
  • Diphosphonates / pharmacology
  • Diphosphonates / therapeutic use*
  • Etidronic Acid / therapeutic use
  • Humans
  • Hypercalcemia / drug therapy*
  • Hypercalcemia / etiology
  • Multiple Myeloma / drug therapy
  • Osteolysis / drug therapy
  • Osteolysis / etiology
  • Pain / drug therapy
  • Pamidronate
  • Structure-Activity Relationship

Substances

  • Diphosphonates
  • Clodronic Acid
  • Etidronic Acid
  • Pamidronate
  • Alendronate